|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00162903 |
|
Date of registration:
|
12/09/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants
|
|
Scientific title:
|
The Role of Nitric Oxide, Endothelin-1, and Inflammatory Mediators in the Patency of Ductus Arteriosus in Preterm Infants |
|
Date of first enrolment:
|
January 2002 |
|
Target sample size:
|
80 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00162903 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Defined Population, Observational Model: Natural History, Time Perspective: Cross-Sectional, Time Perspective: Prospective
|
|
|
Contacts
|
|
Name:
|
Wu Shiun Hsieh, M.D |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National Taiwan University Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Clinical diagnosis of the patency of ductus arteriosus
Exclusion Criteria:
- Congenital anomalies
Age minimum:
N/A
Age maximum:
1 Year
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Patent Ductus Arteriosus
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|